Arpeggio Bio
BOULDER, CO, United States · Biotechnology, Information Technology · 9 employees
Arpeggio Biosciences is revolutionizing drug discovery by combining a proprietary biological assay with machine learning algorithms to generate rapid, high-resolution snapshots of cellular dynamics following drug treatment. These snapshots uncover the biological networks that drive a drug’s function, guiding more effective therapeutic development. Backed by a talented and diverse team, Arpeggio is
Funding history
- Funding Round — $20.0M — Nov 2025
- Series seed — $4.0M — Mar 2025
- Funding Round — $20.2M — Sep 2022
- Series series a — $17.0M — Sep 2022
- Funding Round — $2.0M — Sep 2019
Recent signals
- Nov 24, 2025: Raised $20.0M
- Mar 27, 2025: Raised $4.0M in Series seed
- Sep 23, 2022: Raised $20.2M
- Sep 07, 2022: Raised $17.0M in Series series a
- Sep 06, 2019: Raised $2.0M
- Aug 29, 2019: Raised $125K
See plans & pricing → Track Arpeggio Bio’s funding, hiring, and signals — with verified contacts — on Fundz.